Robert Lilja is the Founder and Managing Partner of Lilja & Co., an independent equity capital markets advisory firm with offices in Zurich and Frankfurt.
Prior to founding Lilja & Co. in 2004, Bob was a Partner at Lazard London, Frankfurt and Stockholm responsible for Equity Advisory. From 1985 to 1994, he was a Director at Credit Suisse First Boston, London responsible for Nordic coverage.
Bob is a former Chairman of the Audit Committee of Nobel Biocare, a Swiss/Swedish listed medtech company where he served on the board for seven years. He is the author of the book “International Equity Markets – The Art of the Deal” published by Euromoney in 1997.
In 1997, Bob carried out a special assignment for the Chairman of the Wellcome Trust in London.
Bob graduated with a Master's Degree (lic. oec. HSG) in Business Administration from the University of St. Gallen in 1982.